Global Parkinson Disease Drug Market Research Report 2024(Status and Outlook)
Report Overview:
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The Global Parkinson Disease Drug Market Size was estimated at USD 5865.62 million in 2023 and is projected to reach USD 8415.13 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Parkinson Disease Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson Disease Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson Disease Drug market in any manner.
Global Parkinson Disease Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Bausch Health
Market Segmentation (by Type)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segmentation (by Application)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson Disease Drug Market
- Overview of the regional outlook of the Parkinson Disease Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson Disease Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Parkinson Disease Drug
- 1.2 Key Market Segments
- 1.2.1 Parkinson Disease Drug Segment by Type
- 1.2.2 Parkinson Disease Drug Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Parkinson Disease Drug Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Parkinson Disease Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Parkinson Disease Drug Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Parkinson Disease Drug Market Competitive Landscape
- 3.1 Global Parkinson Disease Drug Sales by Manufacturers (2019-2024)
- 3.2 Global Parkinson Disease Drug Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Parkinson Disease Drug Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Parkinson Disease Drug Sales Sites, Area Served, Product Type
- 3.6 Parkinson Disease Drug Market Competitive Situation and Trends
- 3.6.1 Parkinson Disease Drug Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Parkinson Disease Drug Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Parkinson Disease Drug Industry Chain Analysis
- 4.1 Parkinson Disease Drug Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Parkinson Disease Drug Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Parkinson Disease Drug Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Parkinson Disease Drug Sales Market Share by Type (2019-2024)
- 6.3 Global Parkinson Disease Drug Market Size Market Share by Type (2019-2024)
- 6.4 Global Parkinson Disease Drug Price by Type (2019-2024)
- 7 Parkinson Disease Drug Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Parkinson Disease Drug Market Sales by Application (2019-2024)
- 7.3 Global Parkinson Disease Drug Market Size (M USD) by Application (2019-2024)
- 7.4 Global Parkinson Disease Drug Sales Growth Rate by Application (2019-2024)
- 8 Parkinson Disease Drug Market Segmentation by Region
- 8.1 Global Parkinson Disease Drug Sales by Region
- 8.1.1 Global Parkinson Disease Drug Sales by Region
- 8.1.2 Global Parkinson Disease Drug Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Parkinson Disease Drug Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Parkinson Disease Drug Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Parkinson Disease Drug Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Parkinson Disease Drug Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Parkinson Disease Drug Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Merck
- 9.1.1 Merck Parkinson Disease Drug Basic Information
- 9.1.2 Merck Parkinson Disease Drug Product Overview
- 9.1.3 Merck Parkinson Disease Drug Product Market Performance
- 9.1.4 Merck Business Overview
- 9.1.5 Merck Parkinson Disease Drug SWOT Analysis
- 9.1.6 Merck Recent Developments
- 9.2 Akorn
- 9.2.1 Akorn Parkinson Disease Drug Basic Information
- 9.2.2 Akorn Parkinson Disease Drug Product Overview
- 9.2.3 Akorn Parkinson Disease Drug Product Market Performance
- 9.2.4 Akorn Business Overview
- 9.2.5 Akorn Parkinson Disease Drug SWOT Analysis
- 9.2.6 Akorn Recent Developments
- 9.3 GSK
- 9.3.1 GSK Parkinson Disease Drug Basic Information
- 9.3.2 GSK Parkinson Disease Drug Product Overview
- 9.3.3 GSK Parkinson Disease Drug Product Market Performance
- 9.3.4 GSK Parkinson Disease Drug SWOT Analysis
- 9.3.5 GSK Business Overview
- 9.3.6 GSK Recent Developments
- 9.4 Novartis
- 9.4.1 Novartis Parkinson Disease Drug Basic Information
- 9.4.2 Novartis Parkinson Disease Drug Product Overview
- 9.4.3 Novartis Parkinson Disease Drug Product Market Performance
- 9.4.4 Novartis Business Overview
- 9.4.5 Novartis Recent Developments
- 9.5 Boehringer Ingelheim
- 9.5.1 Boehringer Ingelheim Parkinson Disease Drug Basic Information
- 9.5.2 Boehringer Ingelheim Parkinson Disease Drug Product Overview
- 9.5.3 Boehringer Ingelheim Parkinson Disease Drug Product Market Performance
- 9.5.4 Boehringer Ingelheim Business Overview
- 9.5.5 Boehringer Ingelheim Recent Developments
- 9.6 Teva Pharmaceutical
- 9.6.1 Teva Pharmaceutical Parkinson Disease Drug Basic Information
- 9.6.2 Teva Pharmaceutical Parkinson Disease Drug Product Overview
- 9.6.3 Teva Pharmaceutical Parkinson Disease Drug Product Market Performance
- 9.6.4 Teva Pharmaceutical Business Overview
- 9.6.5 Teva Pharmaceutical Recent Developments
- 9.7 Abbvie
- 9.7.1 Abbvie Parkinson Disease Drug Basic Information
- 9.7.2 Abbvie Parkinson Disease Drug Product Overview
- 9.7.3 Abbvie Parkinson Disease Drug Product Market Performance
- 9.7.4 Abbvie Business Overview
- 9.7.5 Abbvie Recent Developments
- 9.8 Kyowa Hakko Kirin Pharma
- 9.8.1 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Basic Information
- 9.8.2 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Overview
- 9.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product Market Performance
- 9.8.4 Kyowa Hakko Kirin Pharma Business Overview
- 9.8.5 Kyowa Hakko Kirin Pharma Recent Developments
- 9.9 Astellas Pharma
- 9.9.1 Astellas Pharma Parkinson Disease Drug Basic Information
- 9.9.2 Astellas Pharma Parkinson Disease Drug Product Overview
- 9.9.3 Astellas Pharma Parkinson Disease Drug Product Market Performance
- 9.9.4 Astellas Pharma Business Overview
- 9.9.5 Astellas Pharma Recent Developments
- 9.10 Desitin Arzneimittel
- 9.10.1 Desitin Arzneimittel Parkinson Disease Drug Basic Information
- 9.10.2 Desitin Arzneimittel Parkinson Disease Drug Product Overview
- 9.10.3 Desitin Arzneimittel Parkinson Disease Drug Product Market Performance
- 9.10.4 Desitin Arzneimittel Business Overview
- 9.10.5 Desitin Arzneimittel Recent Developments
- 9.11 Endo Pharmaceuticals
- 9.11.1 Endo Pharmaceuticals Parkinson Disease Drug Basic Information
- 9.11.2 Endo Pharmaceuticals Parkinson Disease Drug Product Overview
- 9.11.3 Endo Pharmaceuticals Parkinson Disease Drug Product Market Performance
- 9.11.4 Endo Pharmaceuticals Business Overview
- 9.11.5 Endo Pharmaceuticals Recent Developments
- 9.12 F.Hoffmann-La Roche
- 9.12.1 F.Hoffmann-La Roche Parkinson Disease Drug Basic Information
- 9.12.2 F.Hoffmann-La Roche Parkinson Disease Drug Product Overview
- 9.12.3 F.Hoffmann-La Roche Parkinson Disease Drug Product Market Performance
- 9.12.4 F.Hoffmann-La Roche Business Overview
- 9.12.5 F.Hoffmann-La Roche Recent Developments
- 9.13 H.Lundbeck
- 9.13.1 H.Lundbeck Parkinson Disease Drug Basic Information
- 9.13.2 H.Lundbeck Parkinson Disease Drug Product Overview
- 9.13.3 H.Lundbeck Parkinson Disease Drug Product Market Performance
- 9.13.4 H.Lundbeck Business Overview
- 9.13.5 H.Lundbeck Recent Developments
- 9.14 Valeant
- 9.14.1 Valeant Parkinson Disease Drug Basic Information
- 9.14.2 Valeant Parkinson Disease Drug Product Overview
- 9.14.3 Valeant Parkinson Disease Drug Product Market Performance
- 9.14.4 Valeant Business Overview
- 9.14.5 Valeant Recent Developments
- 9.15 Apokyn
- 9.15.1 Apokyn Parkinson Disease Drug Basic Information
- 9.15.2 Apokyn Parkinson Disease Drug Product Overview
- 9.15.3 Apokyn Parkinson Disease Drug Product Market Performance
- 9.15.4 Apokyn Business Overview
- 9.15.5 Apokyn Recent Developments
- 9.16 Orion
- 9.16.1 Orion Parkinson Disease Drug Basic Information
- 9.16.2 Orion Parkinson Disease Drug Product Overview
- 9.16.3 Orion Parkinson Disease Drug Product Market Performance
- 9.16.4 Orion Business Overview
- 9.16.5 Orion Recent Developments
- 9.17 Stada Arzneimittel
- 9.17.1 Stada Arzneimittel Parkinson Disease Drug Basic Information
- 9.17.2 Stada Arzneimittel Parkinson Disease Drug Product Overview
- 9.17.3 Stada Arzneimittel Parkinson Disease Drug Product Market Performance
- 9.17.4 Stada Arzneimittel Business Overview
- 9.17.5 Stada Arzneimittel Recent Developments
- 9.18 US WorldMeds
- 9.18.1 US WorldMeds Parkinson Disease Drug Basic Information
- 9.18.2 US WorldMeds Parkinson Disease Drug Product Overview
- 9.18.3 US WorldMeds Parkinson Disease Drug Product Market Performance
- 9.18.4 US WorldMeds Business Overview
- 9.18.5 US WorldMeds Recent Developments
- 9.19 Bausch Health
- 9.19.1 Bausch Health Parkinson Disease Drug Basic Information
- 9.19.2 Bausch Health Parkinson Disease Drug Product Overview
- 9.19.3 Bausch Health Parkinson Disease Drug Product Market Performance
- 9.19.4 Bausch Health Business Overview
- 9.19.5 Bausch Health Recent Developments
- 10 Parkinson Disease Drug Market Forecast by Region
- 10.1 Global Parkinson Disease Drug Market Size Forecast
- 10.2 Global Parkinson Disease Drug Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Parkinson Disease Drug Market Size Forecast by Country
- 10.2.3 Asia Pacific Parkinson Disease Drug Market Size Forecast by Region
- 10.2.4 South America Parkinson Disease Drug Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Parkinson Disease Drug by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Parkinson Disease Drug Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Parkinson Disease Drug by Type (2025-2030)
- 11.1.2 Global Parkinson Disease Drug Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Parkinson Disease Drug by Type (2025-2030)
- 11.2 Global Parkinson Disease Drug Market Forecast by Application (2025-2030)
- 11.2.1 Global Parkinson Disease Drug Sales (Kilotons) Forecast by Application
- 11.2.2 Global Parkinson Disease Drug Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook